TWI711469B - Antimicrobial composition and preparation method thereof - Google Patents

Antimicrobial composition and preparation method thereof Download PDF

Info

Publication number
TWI711469B
TWI711469B TW107131755A TW107131755A TWI711469B TW I711469 B TWI711469 B TW I711469B TW 107131755 A TW107131755 A TW 107131755A TW 107131755 A TW107131755 A TW 107131755A TW I711469 B TWI711469 B TW I711469B
Authority
TW
Taiwan
Prior art keywords
antimicrobial composition
acid
agent
composition according
aqueous solution
Prior art date
Application number
TW107131755A
Other languages
Chinese (zh)
Other versions
TW202010522A (en
Inventor
李仁譯
林芷儀
劉文婷
Original Assignee
寶齡富錦生技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 寶齡富錦生技股份有限公司 filed Critical 寶齡富錦生技股份有限公司
Priority to TW107131755A priority Critical patent/TWI711469B/en
Publication of TW202010522A publication Critical patent/TW202010522A/en
Application granted granted Critical
Publication of TWI711469B publication Critical patent/TWI711469B/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)

Abstract

An antimicrobial composition is provided. The antimicrobial composition includes a cationic antimicrobial agent, a non-ionic surfactant, an acid-base regulator, and a colorant. A preparation method of antimicrobial composition is also provided. The preparation method includes the following steps: providing a non-ionic surfactant solution, mixing an acid-base regulator which is carboxyl group-containing organic acid and a non-ionic surfactant solution, and mixing a colorant, a cationic antimicrobial agent, and the pH adjusted non-ionic surfactant solution to obtain the antimicrobial composition.

Description

抗微生物組合物及其製備方法 Antimicrobial composition and preparation method thereof

本發明是有關於一種抗微生物組合物及其製備方法,且特別是有關於一種具有陽離子抗微生物劑的抗微生物組合物及其製備方法。 The present invention relates to an antimicrobial composition and a preparation method thereof, and particularly relates to an antimicrobial composition with a cationic antimicrobial agent and a preparation method thereof.

許多感染性疾病係以接觸傳播,例如皮膚與皮膚之間的接觸、或皮膚與環境中帶有病原體的表面接觸。現今人口密集度高,使得在公共場所因為上述兩種原因接觸到病原體的機會增高,若接觸病原體後未清潔就觸摸口鼻會有非常高的感染風險。 Many infectious diseases are spread by contact, such as skin-to-skin contact, or skin-to-environmental surfaces with pathogens. The high population density nowadays increases the chance of exposure to pathogens in public places due to the above two reasons. If the mouth and nose are not cleaned after contact with pathogens, there is a very high risk of infection.

作為第一線照護病患的醫院,同時也是病菌聚集的主要區域。在醫院中,醫護人員、病患及家屬都有機會接觸到病原體,尤其是醫療人員有極高的機率成為傳播病菌的媒介。曾有研究針對醫護人員的雙手、工作服、聽診器及工作臺上進行採檢,都培養出具抗藥性的菌株,若在醫院沒有做好感染控制,將會帶給病患極大的威脅性。 As the first-line hospital to care for patients, it is also the main area where germs gather. In the hospital, medical staff, patients and their families have the opportunity to come into contact with pathogens, especially medical staff have a very high probability of becoming a medium for spreading germs. There have been studies conducted on the hands, work clothes, stethoscopes and workbenches of medical staff. They have cultivated resistant strains. If infection control is not done in the hospital, it will bring great threat to patients.

為了降低前述各種的感染風險,發展出許多抗微生物組合物。陽離子抗微生物劑常作為市售抗微生物組合 物的主要活性成分,然而陽離子抗微生物劑的性質較不穩定容易產生沉澱,在工業上的製程相當不易。其中,葡萄糖酸氯己定(Chlorhexidine Gluconate)這種陽離子抗微生物劑在處方配製上有許多限制,例如:(1)因葡萄糖酸氯己定為陽離子性的化合物,遇到陰離子性物質會形成難溶於水的鹽類而產生沉澱,並可能導致抗微生物能力的降低;(2)葡萄糖酸氯己定在與陽離子性界面活性劑或非離子性界面活性劑搭配使用時,高濃度的界面活性劑會形成微胞(micelle)而降低葡萄糖酸氯己定抗微生物能力;(3)當葡萄糖酸氯己定濃度超過0.05%(重量/體積百分比)時,遇到無機酸、部分的有機酸及其鹽類(如:苯甲酸鹽(benzoates)、碳酸氫鹽(bicarbonates)、硼酸鹽(borates)、碳酸鹽(carbonates)、氯化物(chlorides)、檸檬酸鹽(citrates)、碘化物(iodides)、硝酸鹽(nitrates)、磷酸鹽(phosphates)及硫酸鹽(sulfates))時容易產生沉澱,若葡萄糖酸氯己定濃度低於0.01%(w/v)時較不會產生沉澱;(4)一般自來水中含有氯離子(Cl-)、碳酸根離子(CO3 2-)、硫酸根離子(SO4 2-)、磷酸根離子(PO4 3-)、鈣離子(Ca2+)、鎂離子(Mg2+)等離子,離子會與葡萄糖酸氯己定結合,而產生沈澱;以及(5)葡萄糖酸氯己定與一些增稠劑不相容,例如阿拉伯膠(acacia)、海藻酸鈉(sodium alginate)、羧甲基纖維素鈉(sodium carboxymethylcellulose)、澱粉(starch)及黃蓍膠(tragacanth)會與葡萄糖酸氯己定反應而產生沉澱。因此,如何發展出製程穩定、且產品不易沉澱的抗微生 物組合物,現有技術實有待改善的必要。 In order to reduce the aforementioned various infection risks, many antimicrobial compositions have been developed. Cationic antimicrobial agents are often used as the main active ingredients of commercially available antimicrobial compositions. However, the nature of cationic antimicrobial agents is relatively unstable and prone to precipitation, and the industrial process is quite difficult. Among them, chlorhexidine gluconate (Chlorhexidine Gluconate), a cationic antimicrobial agent, has many restrictions in the formulation, for example: (1) Because chlorhexidine gluconate is a cationic compound, it will be difficult to form when encountering anionic substances. Salts soluble in water cause precipitation and may lead to a decrease in antimicrobial ability; (2) Chlorhexidine gluconate when used with cationic surfactants or nonionic surfactants, high concentration of interfacial activity The agent will form micelles and reduce the antimicrobial ability of chlorhexidine gluconate; (3) When the concentration of chlorhexidine gluconate exceeds 0.05% (weight/volume percentage), it will encounter inorganic acids, some organic acids and Its salts (such as: benzoates, bicarbonates, borates, carbonates, chlorides, citrates, iodides) ), nitrates, phosphates and sulfates are prone to precipitation. If the concentration of chlorhexidine gluconate is less than 0.01% (w/v), precipitation will not occur; (4) ) general tap water contains chlorine ions (Cl -), carbonate ions (CO 3 2-), sulfate ion (SO 4 2-), phosphate ion (PO 4 3-), calcium (Ca 2+), Magnesium ion (Mg 2+ ) ion will combine with chlorhexidine gluconate to produce precipitation; and (5) chlorhexidine gluconate is incompatible with some thickening agents, such as acacia, alginic acid Sodium (sodium alginate), sodium carboxymethylcellulose (sodium carboxymethylcellulose), starch (starch) and tragacanth (tragacanth) will react with chlorhexidine gluconate to produce precipitation. Therefore, how to develop an antimicrobial composition with a stable process and a product that is not easy to precipitate, the existing technology needs to be improved.

本揭示內容的目的在於提供一種抗微生物組合物,其含有陽離子抗微生物劑但不易產生沉澱。 The purpose of the present disclosure is to provide an antimicrobial composition, which contains a cationic antimicrobial agent but does not easily produce precipitation.

本揭示內容提供了一種抗微生物組合物,包含陽離子抗微生物劑、非離子型界面活性劑、酸鹼調節劑、以及著色劑,其中酸鹼調節劑為含有羧基的有機酸。 The present disclosure provides an antimicrobial composition comprising a cationic antimicrobial agent, a non-ionic surfactant, an acid-base regulator, and a coloring agent, wherein the acid-base regulator is an organic acid containing a carboxyl group.

在一些實施方式中,陽離子抗微生物劑包含但不限於氯己定(chlorhexidine)、氯己定的鹽類、聚六亞甲基雙胍(polyhexamethylene biguanide)、鹵苄烷銨(benzalkonium halides)或其組合。鹵苄烷銨包含但不限於氯化苄烷銨(benzalkonium chloride)、溴化苄烷銨(benzalkonium bromide)或其組合。 In some embodiments, the cationic antimicrobial agent includes, but is not limited to, chlorhexidine, salts of chlorhexidine, polyhexamethylene biguanide, benzalkonium halides, or combinations thereof . The benzalkonium halides include, but are not limited to, benzalkonium chloride, benzalkonium bromide, or a combination thereof.

在一些實施方式中,氯己定的鹽類包括但不限於葡萄糖酸氯己定(chlorhexidine gluconate)、二葡萄糖酸氯己定(chlorhexidine digluconate)、二乙酸氯己定(chlorhexidine diacetate)、鹽酸氯己定(chlorhexidine hydrochloride)或其組合。 In some embodiments, the salts of chlorhexidine include, but are not limited to, chlorhexidine gluconate, chlorhexidine digluconate, chlorhexidine diacetate, and chlorhexidine hydrochloride. Set (chlorhexidine hydrochloride) or a combination thereof.

在一些實施方式中,非離子型界面活性劑包含,但不限於癸基葡萄糖苷(decyl glucoside)、椰油醯二乙醇胺(cocamide dea)、聚氧乙烯烷基醚(polyoxyethylene alkyl ether)、聚山梨醇酯二十(polysorbate 20)或其組合。 In some embodiments, the non-ionic surfactant includes, but is not limited to, decyl glucoside, cocamide dea, polyoxyethylene alkyl ether, polysorbate Polysorbate 20 or a combination thereof.

在一些實施方式中,酸鹼調節劑包含,但不限於乳酸、檸檬酸或其組合。 In some embodiments, the acid-base regulator includes, but is not limited to, lactic acid, citric acid, or a combination thereof.

在一些實施方式中,著色劑包含,但不限於酒石黃(FD & C Yellow No.5,tartrazine)、胭脂紅(ponceau 4R)、亮藍(brilliant blue FCF)、日落黃(sunset yellow)、喹啉黃(D & C Yellow No.10,quinoline yellow)、酸性紅33(D & C Red No.33)、誘惑紅(allura red)或其組合。 In some embodiments, the colorant includes, but is not limited to, tartrazine (FD & C Yellow No. 5, tartrazine), ponceau (ponceau 4R), brilliant blue (FCF), sunset yellow (sunset yellow), Quinoline yellow (D & C Yellow No. 10, quinoline yellow), acid red 33 (D & C Red No. 33), allura red (allura red) or a combination thereof.

、在一些實施方式中,抗微生物組合物的總體積以100%計,陽離子抗微生物劑的重量/體積百分比為0.5%至4%,非離子型界面活性劑的重量/體積百分比為3.5%至10.5%,酸鹼調節劑的重量/體積百分比為0.13%至0.18%,以及著色劑的重量/體積百分比為0.00002%至0.036%。 In some embodiments, the total volume of the antimicrobial composition is 100%, the weight/volume percentage of the cationic antimicrobial agent is 0.5% to 4%, and the weight/volume percentage of the nonionic surfactant is 3.5% to 10.5%, the weight/volume percentage of the acid-base regulator is 0.13% to 0.18%, and the weight/volume percentage of the coloring agent is 0.00002% to 0.036%.

在一些實施方式中,陽離子抗微生物劑為葡萄糖酸氯己定且重量/體積百分比為1.6%至2.4%。 In some embodiments, the cationic antimicrobial agent is chlorhexidine gluconate and the weight/volume percentage is 1.6% to 2.4%.

在一些實施方式中,著色劑為酒石黃且重量/體積百分比為0.00002%至0.00006%。 In some embodiments, the colorant is tartrazine and the weight/volume percentage is 0.00002% to 0.00006%.

在一些實施方式中,抗微生物組合物更包含增稠劑。 In some embodiments, the antimicrobial composition further includes a thickener.

在一些實施方式中,增稠劑包含,但不限於羥乙基纖維素(hydroxy ethylcellulose)、羥丙基纖維素(hydroxypropyl cellulose)、羥丙基甲基纖維素(hydroxypropyl methylcellulose)或其組合。 In some embodiments, the thickener includes, but is not limited to, hydroxy ethylcellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, or a combination thereof.

在一些實施方式中,抗微生物組合物更包含保 濕劑。 In some embodiments, the antimicrobial composition further includes a moisture retention agent.

在一些實施方式中,保濕劑包含,但不限於甘油(glycerol)、丙二醇(propylene glycol)、山梨醇(sorbitol)或其組合。 In some embodiments, the humectant includes, but is not limited to, glycerol, propylene glycol, sorbitol, or a combination thereof.

在一些實施方式中,抗微生物組合物更包含消泡劑。 In some embodiments, the antimicrobial composition further includes an antifoaming agent.

在一些實施方式中,消泡劑包含,但不限於異丙醇(isopropyl alcohol)、乙醇(ethanol)或其組合。 In some embodiments, the antifoaming agent includes, but is not limited to, isopropyl alcohol, ethanol, or a combination thereof.

在一些實施方式中,抗微生物組合物更包含增稠劑、保濕劑以及消泡劑,其中,抗微生物組合物的總體積以100%計,陽離子抗微生物劑的重量/體積百分比為0.5%至4%,非離子型界面活性劑的重量/體積百分比為3.5%至10.5%,酸鹼調節劑的重量/體積百分比為0.13%至0.18%,著色劑的重量/體積百分比為0.00002%至0.036%,增稠劑的重量/體積百分比為0.27%至0.35%,保濕劑的重量/體積百分比為0.1%至5.0%,以及消泡劑的重量/體積百分比為1.0%至4.0%。 In some embodiments, the antimicrobial composition further includes a thickening agent, a humectant and an antifoaming agent, wherein the total volume of the antimicrobial composition is 100%, and the weight/volume percentage of the cationic antimicrobial agent is 0.5% to 4%, the weight/volume percentage of non-ionic surfactant is 3.5% to 10.5%, the weight/volume percentage of acid-base regulator is 0.13% to 0.18%, and the weight/volume percentage of colorant is 0.00002% to 0.036% , The weight/volume percentage of the thickener is 0.27% to 0.35%, the weight/volume percentage of the humectant is 0.1% to 5.0%, and the weight/volume percentage of the defoamer is 1.0% to 4.0%.

在一些實施方式中,抗微生物組合物係盛裝於容器中,其中容器的材質包含,但不限於高密度聚乙烯、低密度聚乙烯、聚乙烯對苯二甲酸酯或其組合。 In some embodiments, the antimicrobial composition is contained in a container, and the material of the container includes, but is not limited to, high-density polyethylene, low-density polyethylene, polyethylene terephthalate, or a combination thereof.

本揭示內容的另一目的在於提供一種抗微生物組合物的製備方法,以達成陽離子抗微生物劑在製備過程中穩定且不產生沉澱的效果。 Another object of the present disclosure is to provide a method for preparing an antimicrobial composition, so as to achieve the effect of stabilizing the cationic antimicrobial agent without precipitation during the preparation process.

本揭示內容提供了一種抗微生物組合物的製備方法,包含:提供非離子型界面活性劑水溶液;混合酸鹼調節劑與非離子型界面活性劑水溶液,其中酸鹼調節劑為含有羧基的有機酸,且用以調整非離子型界面活性劑水溶液之酸鹼值;以及混合著色劑、陽離子抗微生物劑、以及經調整酸鹼值的非離子型界面活性劑水溶液,以得到抗微生物組合物。 The present disclosure provides a method for preparing an antimicrobial composition, comprising: providing a non-ionic surfactant aqueous solution; mixing an acid-base regulator and a non-ionic surfactant aqueous solution, wherein the acid-base regulator is an organic acid containing a carboxyl group , And used to adjust the pH value of the nonionic surfactant aqueous solution; and mix the colorant, the cationic antimicrobial agent, and the adjusted pH value of the nonionic surfactant aqueous solution to obtain an antimicrobial composition.

在一些實施方式中,非離子型界面活性劑包含癸基葡萄糖苷、椰油醯二乙醇胺、聚氧乙烯烷基醚、聚山梨醇酯二十或其組合。 In some embodiments, the non-ionic surfactant comprises decyl glucoside, coco diethanolamine, polyoxyethylene alkyl ether, polysorbate twenty or a combination thereof.

在一些實施方式中,混合酸鹼調節劑與非離子型界面活性劑水溶液中的步驟中,酸鹼調節劑為乳酸,調整後的酸鹼值為pH5.5至pH6.5。 In some embodiments, in the step of mixing the acid-base regulator and the nonionic surfactant aqueous solution, the acid-base regulator is lactic acid, and the adjusted acid-base value is pH 5.5 to pH 6.5.

在一些實施方式中,陽離子抗微生物劑為葡萄糖酸氯己定,該葡萄糖酸氯己定的重量/體積百分比為2%。 In some embodiments, the cationic antimicrobial agent is chlorhexidine gluconate, and the weight/volume percentage of chlorhexidine gluconate is 2%.

在一些實施方式中,提供非離子型界面活性劑水溶液步驟,包含:混合保濕劑、增稠劑與水,以得到具有保濕劑與增稠劑的水溶液;以及將具有保濕劑與增稠劑的水溶液與非離子型界面活性劑混合,而形成非離子型界面活性劑水溶液。 In some embodiments, the step of providing an aqueous solution of a nonionic surfactant includes: mixing a humectant, a thickener and water to obtain an aqueous solution with a humectant and a thickener; The aqueous solution is mixed with the nonionic surfactant to form an aqueous solution of the nonionic surfactant.

在一些實施方式中,混合著色劑、陽離子抗微生物劑、以及經調整酸鹼值的非離子型界面活性劑水溶液步驟,包含:混合著色劑、陽離子抗微生物劑、以及經調整酸鹼值的非離子型界面活性劑水溶液,再混合一消泡劑,以得 到抗微生物組合物。 In some embodiments, the step of mixing the colorant, the cationic antimicrobial agent, and the pH-adjusted nonionic surfactant aqueous solution includes: mixing the colorant, the cationic antimicrobial agent, and the pH-adjusted nonionic surfactant solution. An aqueous solution of an ionic surfactant is mixed with a defoamer to obtain an antimicrobial composition.

承上所述,由於陽離子抗微生物劑的化學性質不穩定,容易與抗微生物組合物中之其他成分反應而產生沉澱,藉由本揭示內容的成分配比以及製備方法,可達成陽離子抗微生物劑在抗微生物組合物中不易產生沉澱的效果。在成分配比方面,使用非離子型界面活性劑而不使用陰離子型界面活性劑和兩性型界面活性劑,以及使用含有羧基之有機酸作為酸鹼調節劑,皆有利於避免陽離子抗微生物劑形成難溶於水的鹽類而發生沉澱。在部分實施例中,特別選用乳酸作為酸鹼調節劑,以及挑選特定的著色劑,並控制著色劑的使用量,可以更進一步增進陽離子抗微生物劑在抗微生物組合物中的穩定性,再減少沉澱發生的量,或是沉澱發生的機會。即使選用屬於陰離子性物質的著色劑,但控制著色劑使用量亦可避免抗微生物劑產生沉澱,且成分中添加的非離子型界面活性劑、多元醇類亦可作為溶劑,額外增加陽離子抗微生物劑與不同著色劑的相容性。 In view of the above, due to the unstable chemical properties of the cationic antimicrobial agent, it is easy to react with other ingredients in the antimicrobial composition to produce precipitation. With the composition ratio and preparation method of the present disclosure, the cationic antimicrobial agent can be The antimicrobial composition is not easy to produce precipitation effect. In terms of composition ratio, the use of non-ionic surfactants instead of anionic surfactants and amphoteric surfactants, and the use of organic acids containing carboxyl groups as acid-base regulators are all helpful to avoid the formation of cationic antimicrobial agents. The salt is hardly soluble in water and precipitates. In some embodiments, lactic acid is particularly selected as the acid-base regulator, and specific coloring agents are selected, and the amount of coloring agent used can be controlled to further improve the stability of the cationic antimicrobial agent in the antimicrobial composition, and reduce The amount of precipitation, or the chance of precipitation. Even if coloring agents that are anionic substances are used, controlling the amount of colorant used can prevent precipitation of antimicrobial agents, and the non-ionic surfactants and polyols added to the ingredients can also be used as solvents to add cationic antimicrobial Compatibility with different colorants.

在製備方法方面,控制製備過程中的pH值,可有效防止陽離子抗微生物劑在抗微生物組合物之製備過程或是儲運中發生沉澱。防止陽離子抗微生物劑在抗微生物組合物中產生沉澱,可確保抗微生物組合物中的陽離子抗微生物劑的含量穩定,而可達到抗微生物的效果。 In terms of the preparation method, controlling the pH value during the preparation process can effectively prevent the cationic antimicrobial agent from precipitating during the preparation process or storage and transportation of the antimicrobial composition. Preventing the cationic antimicrobial agent from generating precipitation in the antimicrobial composition can ensure that the content of the cationic antimicrobial agent in the antimicrobial composition is stable, and can achieve the antimicrobial effect.

為了使本揭示內容的敘述更加詳盡與完備,下文詳細描述本發明之實施方式與具體實施例;但這並非實施或運用本揭示內容具體實施例的唯一形式。以下所揭示的各實施例,在有益的情形下可相互組合或取代,也可在一實施例中附加其他的實施例,而無須進一步的記載或說明。 In order to make the description of the present disclosure more detailed and complete, the following describes the implementation and specific embodiments of the present invention in detail; but this is not the only way to implement or use the specific embodiments of the present disclosure. The embodiments disclosed below can be combined or substituted with each other under beneficial circumstances, and other embodiments can also be added to an embodiment without further description or description.

於本文中所使用之「包含」、「包括」、「具有」及相似詞彙,指明其所記載的特徵、區域、整數、步驟、操作、元件與/或組件,但不排除其它的特徵、區域、整數、步驟、操作、元件、組件,與/或其中之群組。 The words "include", "include", "have" and similar words used in this text indicate the recorded features, regions, integers, steps, operations, elements and/or components, but do not exclude other features and regions , Integers, steps, operations, elements, components, and/or groups thereof.

本文中,術語「容器」在文中表示包含、但不限於固定形狀或非固定形狀,例如袋體、罐體、管體或瓶體。 Herein, the term "container" is used in the text to include, but is not limited to, a fixed shape or a non-fixed shape, such as a bag, a can, a tube, or a bottle.

本發明各種實施方式之抗微生物組合物主要包含陽離子抗微生物劑、非離子型界面活性劑、酸鹼調節劑與著色劑。其他如增稠劑、保濕劑、消泡劑、香料等視產品需求添加。 The antimicrobial composition of various embodiments of the present invention mainly includes a cationic antimicrobial agent, a nonionic surfactant, an acid-base regulator and a coloring agent. Others such as thickeners, humectants, defoamers, fragrances, etc. are added according to product requirements.

陽離子抗微生物劑包含但不限於氯己定、氯己定的鹽類、聚六亞甲基雙胍、鹵苄烷銨或其組合。氯己定的鹽類包含但不限於葡萄糖酸氯己定、二葡萄糖酸氯己定、二乙酸氯己定、鹽酸氯己定或其組合。鹵苄烷銨包含但不限於氯化苄烷銨、溴化苄烷銨或其組合。陽離子抗微生物劑的濃度為0.5重量/體積百分比(w/v%)至4w/v%。在一些實施方式中,葡萄糖酸氯己定的濃度可為0.5w/v%、1w/v%、1.5 w/v%、2w/v%、2.5w/v%、3w/v%、3.5w/v%或4w/v%。陽離子抗微生物劑為抗微生物組合物中主要的活性成分,其係以帶正電的分子與微生物細胞壁上帶負電的部位結合,使微生物細胞壁受到破壞,導致細胞內容物洩漏,進而使細胞死亡,以達到抗微生物之功效。 Cationic antimicrobial agents include, but are not limited to, chlorhexidine, chlorhexidine salts, polyhexamethylene biguanide, benzalkonium halides, or combinations thereof. Salts of chlorhexidine include, but are not limited to, chlorhexidine gluconate, chlorhexidine digluconate, chlorhexidine diacetate, chlorhexidine hydrochloride, or a combination thereof. The benzalkonium halides include, but are not limited to, benzalkonium chloride, benzalkonium bromide, or a combination thereof. The concentration of the cationic antimicrobial agent ranges from 0.5 weight/volume percentage (w/v%) to 4w/v%. In some embodiments, the concentration of chlorhexidine gluconate may be 0.5w/v%, 1w/v%, 1.5w/v%, 2w/v%, 2.5w/v%, 3w/v%, 3.5w /v% or 4w/v%. Cationic antimicrobial agent is the main active ingredient in the antimicrobial composition. It combines positively charged molecules with negatively charged parts on the microbial cell wall, destroying the microbial cell wall, causing leakage of cell contents, and cell death. To achieve anti-microbial effect.

非離子型界面活性劑包含但不限於癸基葡萄糖苷、椰油醯二乙醇胺、聚氧乙烯烷基醚、聚山梨醇酯二十或其組合,非離子型界面活性劑濃度為3.5w/v%至10.5w/v%。在一些實施例中,非離子型界面活性劑為鹼性非離子型界面活性劑,例如為癸基葡萄糖苷,且癸基葡萄糖苷的濃度為3.5w/v%、3.57w/v%、4w/v%、4.5w/v%、5w/v%、5.5w/v%、6w/v%、6.5w/v%、7w/v%、7.5w/v%、8w/v%、8.5w/v%、9w/v%、9.5w/v%、10w/v%或10.5w/v%。非離子型界面活性劑其親水端不具電荷,溶於水中時不會發生解離,所以穩定性高,不易受強電解質存在的影響,也不易受酸鹼的影響。因此,使用非離子型界面活性劑,幾乎不會與陽離子抗微生物劑反應而發生沉澱。 Non-ionic surfactants include, but are not limited to, decyl glucoside, coconut oil diethanolamine, polyoxyethylene alkyl ether, polysorbate twenty or a combination thereof, and the concentration of non-ionic surfactant is 3.5 w/v % To 10.5w/v%. In some embodiments, the nonionic surfactant is a basic nonionic surfactant, for example, decyl glucoside, and the concentration of decyl glucoside is 3.5w/v%, 3.57w/v%, 4w /v%, 4.5w/v%, 5w/v%, 5.5w/v%, 6w/v%, 6.5w/v%, 7w/v%, 7.5w/v%, 8w/v%, 8.5w /v%, 9w/v%, 9.5w/v%, 10w/v% or 10.5w/v%. Non-ionic surfactants have no charge at the hydrophilic end and will not dissociate when dissolved in water, so they have high stability and are not easily affected by the presence of strong electrolytes, and are not easily affected by acids and bases. Therefore, the use of non-ionic surfactants hardly react with cationic antimicrobial agents to cause precipitation.

酸鹼調節劑包含但不限於含有羧基的有機酸。含有羧基的有機酸包含乳酸(lactic acid)、檸檬酸(citric acid)或其組合,酸鹼調節劑的濃度為0.13w/v%至0.18w/v%。在一些實施例中,酸鹼調節劑為乳酸,且乳酸的濃度為0.13w/v%、0.14w/v%、0.15w/v%、0.16w/v%、0.17w/v%、或0.18w/v%。選擇含有羧基的有機酸作為酸鹼調節劑的主要優點為其不易與陽離子抗微生物劑反應 而產生沉澱。一般來說,常見的酸鹼調節劑都是無機酸,如鹽酸、硫酸。但是這些無機酸屬強電解質,溶於水中可完全解離出氫離子和其共軛鹼離子,其共軛鹼離子容易和陽離子抗微生物劑反應而生成不溶於水的鹽類。而有機酸,尤其是如含有羧基的有機酸,屬弱電解質,溶於水中只能部分解離,較不易與陽離子抗微生物劑產生反應。較佳地,可選用乳酸作為酸鹼調節劑,除了價格便宜且容易取得外,相較於其他酸鹼調節劑。例如葡萄糖酸內酯,使用乳酸調整溶液pH值所需之用量較少,這是由於乳酸的pH值(pH1.75,10w/v%的乳酸水溶液)比葡萄糖酸內酯的pH值(pH3.6)低,而可較快將溶液調整至目標pH值,例如將pH值調節至pH7以下。 Acid-base regulators include, but are not limited to, organic acids containing carboxyl groups. The carboxyl-containing organic acid includes lactic acid, citric acid or a combination thereof, and the concentration of the acid-base regulator is 0.13 w/v% to 0.18 w/v%. In some embodiments, the acid-base regulator is lactic acid, and the concentration of lactic acid is 0.13w/v%, 0.14w/v%, 0.15w/v%, 0.16w/v%, 0.17w/v%, or 0.18 w/v%. The main advantage of choosing organic acids containing carboxyl groups as acid-base regulators is that they are not easy to react with cationic antimicrobial agents to produce precipitation. Generally speaking, the common acid-base regulators are inorganic acids, such as hydrochloric acid and sulfuric acid. However, these inorganic acids are strong electrolytes and can completely dissociate hydrogen ions and their conjugate alkali ions when dissolved in water, and their conjugate alkali ions can easily react with cationic antimicrobial agents to form water-insoluble salts. Organic acids, especially those containing carboxyl groups, are weak electrolytes and can only be partially dissociated when dissolved in water, and are less likely to react with cationic antimicrobial agents. Preferably, lactic acid can be selected as the acid-base regulator, which is cheaper and easily available compared to other acid-base regulators. For example, gluconolactone, the use of lactic acid to adjust the pH of the solution requires less amount, because the pH value of lactic acid (pH1.75, 10w/v% lactic acid aqueous solution) is higher than the pH value of gluconolactone (pH3. 6) It is low, and the solution can be adjusted to the target pH value quickly, for example, the pH value is adjusted to pH 7 or less.

依照需求可選擇添加不同顏色的著色劑,例如使用於人體皮膚表面之抗微生物組合物或是使用於環境清潔之抗微生物組合物,可選擇添加不同顏色的著色劑做為區隔。此外,添加些許著色劑使抗微生物組合物具有顏色,使用時可直接以肉眼辨識塗抹的區域,亦為著色劑之用途。著色劑包含,但不限於酒石黃、胭脂紅、亮藍、日落黃、喹啉黃、酸性紅33、誘惑紅或其組合,著色劑於抗微生物組合物中的濃度為0.00002w/v%至0.036w/v%,以免陽離子抗微生物劑發生沉澱。在一些實施例中,著色劑於抗微生物組合物中的濃度為可為0.00002w/v%至0.006w/v%,較佳為0.00002w/v%至0.00006w/v%。在一些實施例中,著色劑為酒石黃,且酒石黃的濃度為0.00002w/v%、 0.00003w/v%、0.00004w/v%、0.00005w/v%或0.00006w/v%。著色劑屬於陰離子性物質,結構上帶有負電易與陽離子抗微生物劑上的正電形成不溶於水的鹽類而產生沉澱。然而,控制著色劑的使用量,如控制於0.036w/v%以下可避免陽離子抗微生物劑反應而發生沉澱。其次,抗微生物組合物中除了水以外的溶劑,如非離子型界面活性劑、多元醇類,亦可增加著色劑與陽離子抗微生物劑的相容性。 Coloring agents of different colors can be added according to requirements, such as antimicrobial compositions used on the surface of human skin or antimicrobial compositions used for environmental cleaning, and coloring agents of different colors can be added as a partition. In addition, adding a little coloring agent to make the antimicrobial composition have a color, and the area to be applied can be directly identified with the naked eye during use, which is also the purpose of the coloring agent. The colorant includes, but is not limited to, tartrazine, carmine, brilliant blue, sunset yellow, quinoline yellow, acid red 33, allure red or a combination thereof, and the concentration of the colorant in the antimicrobial composition is 0.00002w/v% To 0.036w/v% to avoid precipitation of cationic antimicrobial agents. In some embodiments, the concentration of the colorant in the antimicrobial composition may be 0.00002w/v% to 0.006w/v%, preferably 0.00002w/v% to 0.00006w/v%. In some embodiments, the colorant is tartrazine, and the concentration of tartrazine is 0.00002w/v%, 0.00003w/v%, 0.00004w/v%, 0.00005w/v%, or 0.00006w/v%. The colorant is an anionic substance, which has a negative charge in its structure and can easily form a water-insoluble salt with the positive charge on the cationic antimicrobial agent to cause precipitation. However, controlling the amount of colorant used, such as controlling it below 0.036w/v%, can prevent cationic antimicrobial agents from reacting and causing precipitation. Secondly, solvents other than water in the antimicrobial composition, such as non-ionic surfactants and polyols, can also increase the compatibility of the colorant and the cationic antimicrobial agent.

增稠劑包含但不限於羥乙基纖維素、羥丙基纖維素、羥丙基甲基纖維素或其組合,且依照需求的稠度調整濃度為0.27w/v%至0.35w/v%,可避免抗微生物組合物裝載於壁掛式按壓瓶等開口朝下之容器中時,不經按壓就流出。在一些實施例中,增稠劑為羥乙基纖維素,且羥乙基纖維素的濃度為0.27w/v%、0.28w/v%、0.29w/v%、0.3w/v%、0.31w/v%、0.32w/v%、0.33w/v%、0.34w/v%或0.35w/v%。 The thickener includes but is not limited to hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose or a combination thereof, and the concentration is adjusted to 0.27w/v% to 0.35w/v% according to the required consistency, It can prevent the antimicrobial composition from flowing out without pressing when it is loaded in a container with the opening facing down, such as a wall-mounted press bottle. In some embodiments, the thickener is hydroxyethyl cellulose, and the concentration of hydroxyethyl cellulose is 0.27w/v%, 0.28w/v%, 0.29w/v%, 0.3w/v%, 0.31 w/v%, 0.32w/v%, 0.33w/v%, 0.34w/v% or 0.35w/v%.

保濕劑包含但不限於甘油、丙二醇、山梨醇或其組合,保濕劑的濃度為0.1w/v%至5.0w/v%。在一些實施例中,保濕劑為甘油,且甘油的濃度為0.1w/v%、1w/v%、2w/v%、3w/v%、4w/v%或5w/v%。由於抗微生物劑中的非離子型界面活性劑會使皮膚角質層的保濕物質流失,造成乾澀感,添加保濕劑可降低刺激、保護皮膚。其次,做為保濕劑所添加的多元醇類亦可增加著色劑與陽離子抗微生物劑的相容性。 The humectant includes but is not limited to glycerin, propylene glycol, sorbitol or a combination thereof, and the concentration of the humectant is 0.1 w/v% to 5.0 w/v%. In some embodiments, the humectant is glycerin, and the concentration of glycerin is 0.1w/v%, 1w/v%, 2w/v%, 3w/v%, 4w/v%, or 5w/v%. Since the non-ionic surfactant in the antimicrobial agent will cause the moisturizing substance in the stratum corneum of the skin to be lost and cause dryness, adding a moisturizer can reduce irritation and protect the skin. Secondly, the polyols added as a humectant can also increase the compatibility of the colorant and the cationic antimicrobial agent.

消泡劑包含,但不限於異丙醇、乙醇或其組合,消泡劑的濃度為1.0w/v%至4.0w/v%。在一些實施例中,消泡劑為異丙醇,且異丙醇的濃度為1w/v%、2w/v%、3w/v%或4w/v%。由於微生物組合物中含有界面活性劑,在製作過程中所產生的泡沫不易消除,雖然泡沫不會影響陽離子抗微生物劑之功效,但是製程中所產生的大量泡沫會影響pH值的判讀及充填的困難。加入消泡劑可改變表面張力,使得泡沫局部表面張力降低而導致泡沫破滅,達成消泡的效果。 The defoamer includes, but is not limited to, isopropanol, ethanol or a combination thereof, and the concentration of the defoamer is 1.0 w/v% to 4.0 w/v%. In some embodiments, the antifoaming agent is isopropanol, and the concentration of isopropanol is 1w/v%, 2w/v%, 3w/v%, or 4w/v%. Because the microbial composition contains surfactants, the foam produced during the production process is not easy to eliminate. Although the foam will not affect the efficacy of the cationic antimicrobial agent, the large amount of foam produced during the process will affect the interpretation of the pH value and the filling difficult. Adding a defoamer can change the surface tension, so that the local surface tension of the foam is reduced and the foam is collapsed, achieving the effect of defoaming.

抗微生物組合物可依照需求選擇添加不同氣味的香料,使用的香料種類及添加量本發明並不限制。 The antimicrobial composition can be selected to add fragrances with different odors according to requirements, and the type and amount of fragrances used are not limited in the present invention.

在一具體實施例中,抗微生物組合物按下表1所列成分比例調製:

Figure 107131755-A0101-12-0012-1
Figure 107131755-A0101-12-0013-2
In a specific embodiment, the antimicrobial composition is prepared according to the ratio of ingredients listed in Table 1:
Figure 107131755-A0101-12-0012-1
Figure 107131755-A0101-12-0013-2

在一具體實施例中,抗微生物組合物係盛裝於一容器中,其中容器的材質選擇避免與葡萄糖酸氯己定反應發生沉澱的現象。容器的材質包含,但不限於聚乙烯(polyethylene)、聚乙烯對苯二甲酸酯(polyethylene terephthalate,PET)或其組合。聚乙烯可分為高密度聚乙烯(high density polyethylene,HDPE)與低密度聚乙烯(low density polyethylene,LDPE)兩種。容器外型可以視使用需求設計,例如為瓶狀或管狀,本發明不限制。 In a specific embodiment, the antimicrobial composition is contained in a container, and the material of the container is selected to avoid precipitation when reacting with chlorhexidine gluconate. The material of the container includes, but is not limited to, polyethylene, polyethylene terephthalate (PET), or a combination thereof. Polyethylene can be divided into high density polyethylene (HDPE) and low density polyethylene (LDPE). The outer shape of the container can be designed according to use requirements, for example, a bottle shape or a tube shape, and the present invention is not limited.

本發明之另一態樣是提供一種抗微生物組合物的製備方法。雖然下文中利用一系列的操作或步驟來說明在此揭露之方法,但是這些操作或步驟所示的順序不應被解釋為本發明的限制。例如,某些操作或步驟可以按不同順序進行及/或與其它步驟同時進行。此外,並非必須執行所有操作、步驟及/或特徵才能實現本發明的實施方式。再者,在此所述的每一個操作或步驟可以包含數個子步驟或動作。 Another aspect of the present invention is to provide a method for preparing the antimicrobial composition. Although a series of operations or steps are used in the following to illustrate the method disclosed herein, the sequence of these operations or steps should not be construed as a limitation of the present invention. For example, certain operations or steps may be performed in a different order and/or simultaneously with other steps. In addition, not all operations, steps, and/or features must be performed to implement the embodiments of the present invention. Furthermore, each operation or step described herein may include several sub-steps or actions.

本發明實施例之抗微生物組合物的製備方法,由以下步驟製備而得: (1)提供一非離子型界面活性劑水溶液;(2)將酸鹼調節劑加入至非離子型界面活性劑水溶液中攪拌至均勻;(3)混合著色劑與純水後,加入至非離子型界面活性劑水溶液中攪拌至均勻;(4)將陽離子抗微生物劑加入至非離子型界面活性劑水溶液中攪拌至均勻;(5)將純水加入至含有非離子型界面活性劑、酸鹼調節劑、著色劑及陽離子抗微生物劑的非離子型界面活性劑水溶液定量後,獲得抗微生物組合物。 The preparation method of the antimicrobial composition of the embodiment of the present invention is prepared by the following steps: (1) Provide a nonionic surfactant aqueous solution; (2) Add acid-base regulator to the nonionic surfactant aqueous solution (3) After mixing the colorant and pure water, add it to the aqueous solution of non-ionic surfactant and stir until uniform; (4) Add the cationic antimicrobial agent to the aqueous solution of non-ionic surfactant and stir to Uniformity; (5) After adding pure water to the non-ionic surfactant aqueous solution containing non-ionic surfactant, acid-base regulator, coloring agent and cationic antimicrobial agent, the antimicrobial composition is obtained after quantitative.

在步驟(1)提供非離子型界面活性劑水溶液時,可將非離子型界面活性劑加入純水中攪拌至均勻而得。在一些實施例中,可先混合保濕劑與增稠劑至分散均勻無結塊後,倒入純水中攪拌至溶解,再加入非離子型界面活性劑攪拌至均勻後,得到非離子型界面活性劑水溶液。 In step (1), when the nonionic surfactant aqueous solution is provided, the nonionic surfactant can be added to pure water and stirred until uniform. In some embodiments, the humectant and the thickener can be mixed first until the dispersion is uniform and there is no agglomeration, then poured into pure water and stirred until dissolved, and then a non-ionic surfactant is added and stirred until uniform to obtain a non-ionic interface Active agent aqueous solution.

在步驟(2)中,酸鹼調節劑為含有羧基的有機酸,用以將非離子型界面活性劑水溶液的pH值自大於pH11調整至pH7以下,較佳為約pH5.5至pH6.5,在一些實施例中則調整至pH5.8至pH6.2之間。由於非離子型界面活性劑的pH值較高,在此步驟調整pH值,可避免後續加入之陽離子抗微生物劑因pH值過高而發生沉澱。酸鹼調節劑較佳可選用乳酸,其優點已詳述於前,在此不再贅述。 In step (2), the acid-base regulator is an organic acid containing a carboxyl group, which is used to adjust the pH value of the aqueous solution of the non-ionic surfactant from greater than pH 11 to less than pH 7, preferably about pH 5.5 to pH 6.5 In some embodiments, it is adjusted to pH 5.8 to pH 6.2. Since the pH value of the non-ionic surfactant is relatively high, adjusting the pH value in this step can avoid precipitation of the cationic antimicrobial agent added later due to the high pH value. The acid-base regulator is preferably lactic acid, the advantages of which have been described in detail above, and will not be repeated here.

在步驟(3)中,由於著色劑的選用及添加的比例會影響陽離子抗微生物劑發生沉澱的可能性,可參考前述著 色劑之選用及添加比例。除著色劑外,可視需求添加香料。可於加入著色劑後,直接於非離子型界面活性劑水溶液中加入香料至攪拌均勻。 In step (3), since the selection and addition ratio of the coloring agent will affect the possibility of precipitation of the cationic antimicrobial agent, refer to the selection and addition ratio of the aforementioned coloring agent. In addition to coloring agents, flavors can be added as required. After adding the coloring agent, add perfume directly to the non-ionic surfactant aqueous solution until it is evenly stirred.

在步驟(4)加入陽離子抗微生物劑之前,需先確認非離子型界面活性劑水溶液的pH值介於pH5.5至6.5之間,防止陽離子抗微生物劑因pH值過高而發生沉澱。 Before adding the cationic antimicrobial agent in step (4), it is necessary to confirm that the pH value of the nonionic surfactant aqueous solution is between pH 5.5 and 6.5 to prevent the cationic antimicrobial agent from precipitating due to excessive pH.

在步驟(5)中,加入純水定量係指將純水補滿至抗微生物組合物所預定製備的重量。例如,預定製備1公升的抗微生物組合物,在步驟(5)即加入純水至最終產物為1公升。最後,測量水溶液之pH值為5.0至7.0,較佳之pH值為6.0至6.5,即獲得抗微生物組合物。在一些實施例中,加入純水之前可先於非離子型界面活性劑水溶液中加入消泡劑攪拌至均勻,以消除非離子型界面活性劑水溶液表面的泡沫。 In step (5), adding pure water quantitatively refers to adding pure water to the weight of the antimicrobial composition intended to be prepared. For example, if it is scheduled to prepare 1 liter of antimicrobial composition, pure water is added in step (5) until the final product is 1 liter. Finally, measure the pH of the aqueous solution to be 5.0 to 7.0, preferably 6.0 to 6.5, to obtain the antimicrobial composition. In some embodiments, prior to adding pure water, a defoamer can be added to the aqueous solution of nonionic surfactant and stirred until uniform, so as to eliminate foam on the surface of the aqueous solution of nonionic surfactant.

在一具體實施例中,抗微生物組合物可依表1所列之成分配比,由前述步驟製備而得。 In a specific embodiment, the antimicrobial composition can be prepared by the aforementioned steps according to the composition ratio listed in Table 1.

在一具體實施例中,抗微生物組合物主要包含陽離子抗微生物劑、非離子型界面活性劑、酸鹼調節劑與著色劑以及溶劑。在一些實施方式中,溶劑為水。其他如增稠劑、保濕劑、消泡劑、香料等視產品需求添加。由於當陽離子抗微生物劑為葡萄糖酸氯己定時,其性質較不穩定容易產生沉澱。為了避免沉澱的產生使得葡萄糖酸氯己定含量降低,進而影響抗微生物效果,配方成分的挑選及製程中的pH值控制為其重要。 In a specific embodiment, the antimicrobial composition mainly includes a cationic antimicrobial agent, a nonionic surfactant, an acid-base regulator, a coloring agent, and a solvent. In some embodiments, the solvent is water. Others such as thickeners, humectants, defoamers, fragrances, etc. are added according to product requirements. Because when the cationic antimicrobial agent is chlorhexidine gluconate, its properties are relatively unstable and easy to produce precipitation. In order to avoid the occurrence of precipitation and reduce the content of chlorhexidine gluconate, which in turn affects the antimicrobial effect, the selection of formula ingredients and the control of pH in the process are important.

非離子型界面活性劑如乙氧基化壬基酚(ethoxylated nonylphenol)有環境荷爾蒙的問題。在一具體實施例中,所使用的非離子型界面活性劑癸基葡萄糖苷具有低生態毒性、易生物降解且耐高溫。由於癸基葡萄糖苷的pH值較高,此時若直接加入葡萄糖酸氯己定會發生沉澱。故製程上需先用乳酸調整pH值再加入葡萄糖酸氯己定,與現有技術在製程最後步驟中才調整pH值不同。 Non-ionic surfactants such as ethoxylated nonylphenol have environmental hormone problems. In a specific embodiment, the nonionic surfactant decyl glucoside used has low ecotoxicity, easy biodegradation and high temperature resistance. Due to the high pH of decyl glucoside, precipitation will occur if chlorhexidine gluconate is directly added at this time. Therefore, in the process, lactic acid is used to adjust the pH value before adding chlorhexidine gluconate, which is different from the prior art that adjusts the pH value in the final step of the process.

再者,為避免葡萄糖酸氯己定與酸鹼調節劑解離出來的陰離子作用產生沉澱,可選用有機酸中含有羧基的有機酸,較佳為乳酸作為酸鹼調節劑。 Furthermore, in order to avoid precipitation caused by the anions dissociated from chlorhexidine gluconate and the acid-base regulator, an organic acid containing carboxyl groups in the organic acid can be selected, preferably lactic acid as the acid-base regulator.

在一具體實施例中,在抗微生物組合物中添加保濕劑可以縮短製程工時,例如,將羥乙基纖維素先分散在多元醇(如:甘油、丙二醇)中再加入至純水中攪拌溶解,如此即不會有未溶解的小塊狀物。具體而言,傳統方法係將羥乙基纖維素直接於純水中攪拌溶解,不僅耗時且要分鍋攪拌,而本實施例之抗微生物組合物的製備方法在相同含量的羥乙基纖維素混合甘油後再加入純水攪拌,只需要傳統方法1/3至1/5的時間且無須分鍋攪拌即可完成製程。 In a specific embodiment, adding a humectant to the antimicrobial composition can shorten the process time. For example, hydroxyethyl cellulose is first dispersed in a polyol (such as glycerin, propylene glycol) and then added to pure water for stirring and dissolution. There will be no undissolved small lumps. Specifically, the traditional method is to directly stir and dissolve hydroxyethyl cellulose in pure water, which is time-consuming and requires separate pot stirring. The preparation method of the antimicrobial composition of this embodiment is based on the same content of hydroxyethyl cellulose. After mixing glycerin with vegetarian, pure water is added and stirred. It only takes 1/3 to 1/5 of the traditional method and does not need to be stirred in a pot to complete the process.

在一具體實施例中,抗微生物組合物的製備方法中在添加葡萄糖酸氯己定後再加入消泡劑如酒精,是為了藉由改變表面張力以消除溶液表面的泡沫。 In a specific embodiment, in the preparation method of the antimicrobial composition, after adding chlorhexidine gluconate, an antifoaming agent such as alcohol is added in order to eliminate foam on the surface of the solution by changing the surface tension.

承上所述,由於陽離子抗微生物劑的化學性質不穩定,容易與抗微生物組合物中之其他成分反應而產生沉澱,藉由本揭示內容的成分配比以及製備方法,可達成陽離 子抗微生物劑在抗微生物組合物中不易產生沉澱的效果。在成分配比方面,使用非離子型界面活性劑而不使用陰離子型界面活性劑和兩性型界面活性劑,以及使用含有羧基之有機酸作為酸鹼調節劑,皆有利於避免陽離子抗微生物劑形成難溶於水的鹽類而發生沉澱。在部分實施例中,特別選用乳酸作為酸鹼調節劑以及挑選特定的著色劑並控制著色劑的使用量,可以更進一步增進陽離子抗微生物劑在抗微生物組合物中的穩定性,再減少沉澱發生的量,或是沉澱發生的機會。即使選用屬於陰離子性物質的著色劑,但控制著色劑使用量亦可避免抗微生物劑產生沉澱,且成分中添加的非離子型界面活性劑、多元醇類亦可作為溶劑,額外增加陽離子抗微生物劑與不同著色劑的相容性。 In view of the above, due to the unstable chemical properties of the cationic antimicrobial agent, it is easy to react with other ingredients in the antimicrobial composition to produce precipitation. With the composition ratio and preparation method of the present disclosure, the cationic antimicrobial agent can be The antimicrobial composition is not easy to produce precipitation effect. In terms of composition ratio, the use of non-ionic surfactants instead of anionic surfactants and amphoteric surfactants, and the use of organic acids containing carboxyl groups as acid-base regulators are all helpful to avoid the formation of cationic antimicrobial agents. The salt is hardly soluble in water and precipitates. In some embodiments, lactic acid is specially selected as the acid-base regulator, and the specific coloring agent is selected and the amount of the coloring agent is controlled, which can further improve the stability of the cationic antimicrobial agent in the antimicrobial composition and reduce the occurrence of precipitation. Or the chance of precipitation occurring. Even if coloring agents that are anionic substances are used, controlling the amount of colorant used can prevent precipitation of antimicrobial agents, and the non-ionic surfactants and polyols added to the ingredients can also be used as solvents to add cationic antimicrobial Compatibility with different colorants.

在製備方法方面,控制製備過程中的pH值,可有效防止陽離子抗微生物劑在抗微生物組合物之製備過程或是儲運中發生沉澱。防止陽離子抗微生物劑在抗微生物組合物中產生沉澱,可確保抗微生物組合物中的陽離子抗微生物劑的含量穩定,而可達到抗微生物的效果。 In terms of the preparation method, controlling the pH value during the preparation process can effectively prevent the cationic antimicrobial agent from precipitating during the preparation process or storage and transportation of the antimicrobial composition. Preventing the cationic antimicrobial agent from generating precipitation in the antimicrobial composition can ensure that the content of the cationic antimicrobial agent in the antimicrobial composition is stable, and can achieve the antimicrobial effect.

雖然本發明已以實施方式揭露如上,然其並非用以限定本發明,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 Although the present invention has been disclosed in the above embodiments, it is not intended to limit the present invention. Anyone familiar with the art can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the protection of the present invention The scope shall be subject to those defined in the attached patent scope.

Claims (22)

一種抗微生物組合物,包含一陽離子抗微生物劑;一非離子型界面活性劑;一酸鹼調節劑,該酸鹼調節劑為含有羧基的有機酸;以及一著色劑;其中該抗微生物組合物的總體積以100%計,該陽離子抗微生物劑的重量/體積百分比為0.5%至4%;該非離子型界面活性劑的重量/體積百分比為3.5%至10.5%;該酸鹼調節劑的重量/體積百分比為0.13%至0.18%;以及該著色劑的重量/體積百分比為0.00002%至0.036%。 An antimicrobial composition comprising a cationic antimicrobial agent; a nonionic surfactant; an acid-base regulator, the acid-base regulator is an organic acid containing a carboxyl group; and a coloring agent; wherein the antimicrobial composition The total volume is calculated as 100%, the weight/volume percentage of the cationic antimicrobial agent is 0.5% to 4%; the weight/volume percentage of the nonionic surfactant is 3.5% to 10.5%; the weight of the acid-base regulator /Volume percentage is 0.13% to 0.18%; and the weight/volume percentage of the colorant is 0.00002% to 0.036%. 如請求項1所述之抗微生物組合物,其中該陽離子抗微生物劑包含氯己定、氯己定的鹽類、聚六亞甲基雙胍、鹵苄烷銨或其組合。 The antimicrobial composition according to claim 1, wherein the cationic antimicrobial agent comprises chlorhexidine, a salt of chlorhexidine, polyhexamethylene biguanide, benzalkonium halide or a combination thereof. 如請求項2所述之抗微生物組合物,其中該氯己定的鹽類包含葡萄糖酸氯己定、二葡萄糖酸氯己定、二乙酸氯己定、鹽酸氯己定或其組合。 The antimicrobial composition according to claim 2, wherein the salt of chlorhexidine comprises chlorhexidine gluconate, chlorhexidine digluconate, chlorhexidine diacetate, chlorhexidine hydrochloride or a combination thereof. 如請求項1所述之抗微生物組合物,其中該非離子型界面活性劑包含癸基葡萄糖苷、椰油醯二乙醇胺、聚氧乙烯烷基醚、聚山梨醇酯二十或其組合。 The antimicrobial composition according to claim 1, wherein the non-ionic surfactant comprises decyl glucoside, coco diethanolamine, polyoxyethylene alkyl ether, polysorbate twentieth or a combination thereof. 如請求項1所述之抗微生物組合物,其中該酸鹼調節劑包含乳酸、檸檬酸或其組合。 The antimicrobial composition according to claim 1, wherein the acid-base regulator comprises lactic acid, citric acid or a combination thereof. 如請求項1所述之抗微生物組合物,其中該著色劑包含酒石黃、胭脂紅、亮藍、日落黃、喹啉黃、酸性紅33、誘惑紅或其組合。 The antimicrobial composition according to claim 1, wherein the colorant comprises tartrazine, carmine, brilliant blue, sunset yellow, quinoline yellow, acid red 33, allure red or a combination thereof. 如請求項1所述之抗微生物組合物,其中該陽離子抗微生物劑為葡萄糖酸氯己定且重量/體積百分比為1.6%至2.4%。 The antimicrobial composition according to claim 1, wherein the cationic antimicrobial agent is chlorhexidine gluconate and the weight/volume percentage is 1.6% to 2.4%. 如請求項1所述之抗微生物組合物,其中該著色劑為酒石黃且重量/體積百分比為0.00002%至0.00006%。 The antimicrobial composition according to claim 1, wherein the colorant is tartrazine and the weight/volume percentage is 0.00002% to 0.00006%. 如請求項1所述之抗微生物組合物,更包含一增稠劑。 The antimicrobial composition according to claim 1, further comprising a thickening agent. 如請求項9所述之抗微生物組合物,其中該增稠劑包含羥乙基纖維素、羥丙基纖維素、羥丙基甲基纖維素或其組合。 The antimicrobial composition according to claim 9, wherein the thickener comprises hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose or a combination thereof. 如請求項1所述之抗微生物組合物,更包含一保濕劑。 The antimicrobial composition according to claim 1, further comprising a humectant. 如請求項11所述之抗微生物組合物,其中該保濕劑包含甘油、丙二醇、山梨醇或其組合。 The antimicrobial composition according to claim 11, wherein the humectant comprises glycerin, propylene glycol, sorbitol or a combination thereof. 如請求項1所述之抗微生物組合物,更包含一消泡劑。 The antimicrobial composition according to claim 1, further comprising an antifoaming agent. 如請求項13所述之抗微生物組合物,其中該消泡劑包含異丙醇、乙醇或其組合。 The antimicrobial composition according to claim 13, wherein the antifoaming agent comprises isopropanol, ethanol or a combination thereof. 如請求項1所述之抗微生物組合物,更包含一增稠劑、一保濕劑以及一消泡劑,其中,該增稠劑的重量/體積百分比為0.27%至0.35%;該保濕劑的重量/體積百分比為0.1%至5.0%;以及該消泡劑的重量/體積百分比為1.0%至4.0%。 The antimicrobial composition according to claim 1, further comprising a thickening agent, a humectant and a defoaming agent, wherein the weight/volume percentage of the thickening agent is 0.27% to 0.35%; The weight/volume percentage is 0.1% to 5.0%; and the weight/volume percentage of the defoamer is 1.0% to 4.0%. 如請求項1至15中任一項所述之抗微生物組合物,係盛裝於一容器中,其中該容器的材質包含高密度聚乙烯、低密度聚乙烯、聚乙烯對苯二甲酸酯或其組合。 The antimicrobial composition according to any one of claims 1 to 15, which is contained in a container, wherein the material of the container comprises high density polyethylene, low density polyethylene, polyethylene terephthalate or Its combination. 一種抗微生物組合物的製備方法,包含:提供一非離子型界面活性劑水溶液;混合一酸鹼調節劑與該非離子型界面活性劑水溶液,其中該酸鹼調節劑為含有羧基的有機酸,且用以調整該非離子型界面活性劑水溶液之酸鹼值;以及 混合一著色劑、一陽離子抗微生物劑、以及經調整酸鹼值的非離子型界面活性劑水溶液,以得到該抗微生物組合物。 A preparation method of an antimicrobial composition comprises: providing a nonionic surfactant aqueous solution; mixing an acid-base regulator and the nonionic surfactant aqueous solution, wherein the acid-base regulator is an organic acid containing a carboxyl group, and Used to adjust the pH value of the non-ionic surfactant aqueous solution; and A colorant, a cationic antimicrobial agent, and an aqueous solution of a non-ionic surfactant with adjusted pH value are mixed to obtain the antimicrobial composition. 如請求項17所述之製備方法,其中該非離子型界面活性劑包含癸基葡萄糖苷、椰油醯二乙醇胺、聚氧乙烯烷基醚、聚山梨醇酯二十或其組合。 The preparation method according to claim 17, wherein the non-ionic surfactant comprises decyl glucoside, coco diethanolamine, polyoxyethylene alkyl ether, polysorbate twenty or a combination thereof. 如請求項17所述之製備方法,其中該混合一酸鹼調節劑與該非離子型界面活性劑水溶液中的步驟中,該酸鹼調節劑為乳酸,調整後的酸鹼值為pH5.5至pH6.5。 The preparation method according to claim 17, wherein in the step of mixing an acid-base regulator and the nonionic surfactant aqueous solution, the acid-base regulator is lactic acid, and the adjusted acid-base value is from pH 5.5 to pH6.5. 如請求項17所述之製備方法,其中該陽離子抗微生物劑為葡萄糖酸氯己定,該葡萄糖酸氯己定的重量/體積百分比為2%。 The preparation method according to claim 17, wherein the cationic antimicrobial agent is chlorhexidine gluconate, and the weight/volume percentage of chlorhexidine gluconate is 2%. 如請求項17所述之製備方法,其中提供該非離子型界面活性劑水溶液步驟,包含:混合一保濕劑、一增稠劑與水,以得到具有該保濕劑與該增稠劑的水溶液;以及將具有該保濕劑與該增稠劑的水溶液與一非離子型界面活性劑混合,而形成該非離子型界面活性劑水溶液。 The preparation method according to claim 17, wherein the step of providing the nonionic surfactant aqueous solution comprises: mixing a humectant, a thickener and water to obtain an aqueous solution with the humectant and the thickener; and The aqueous solution containing the humectant and the thickener is mixed with a non-ionic surfactant to form the non-ionic surfactant aqueous solution. 如請求項17或21所述之製備方法,其 中混合該著色劑、陽離子抗微生物劑、以及經調整酸鹼值的非離子型界面活性劑水溶液步驟,包含:混合該著色劑、陽離子抗微生物劑、以及經調整酸鹼值的非離子型界面活性劑水溶液,再混合一消泡劑,以得到該抗微生物組合物。 The preparation method according to claim 17 or 21, which The step of mixing the colorant, the cationic antimicrobial agent, and the pH-adjusted nonionic surfactant aqueous solution includes: mixing the colorant, the cationic antimicrobial agent, and the pH-adjusted nonionic interface The active agent aqueous solution is mixed with a defoamer to obtain the antimicrobial composition.
TW107131755A 2018-09-10 2018-09-10 Antimicrobial composition and preparation method thereof TWI711469B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW107131755A TWI711469B (en) 2018-09-10 2018-09-10 Antimicrobial composition and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW107131755A TWI711469B (en) 2018-09-10 2018-09-10 Antimicrobial composition and preparation method thereof

Publications (2)

Publication Number Publication Date
TW202010522A TW202010522A (en) 2020-03-16
TWI711469B true TWI711469B (en) 2020-12-01

Family

ID=70766803

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107131755A TWI711469B (en) 2018-09-10 2018-09-10 Antimicrobial composition and preparation method thereof

Country Status (1)

Country Link
TW (1) TWI711469B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI626006B (en) * 2015-04-02 2018-06-11 布友羅爾有限公司 Anti-microbial composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI626006B (en) * 2015-04-02 2018-06-11 布友羅爾有限公司 Anti-microbial composition

Also Published As

Publication number Publication date
TW202010522A (en) 2020-03-16

Similar Documents

Publication Publication Date Title
CN101808637B (en) Pharmaceutical composition
JP2002524398A (en) Stabilized two-part disinfection systems and related compositions and methods
US10849952B2 (en) Hand sanitizer composition and method of manufacture
JPH06199700A (en) Quick-drying gel-type disinfectant for finger
US20050019291A1 (en) Emulsion composition of polyvinyl alcohol which forms a peelable film on skin
JP6252475B2 (en) External preparation composition
KR100878198B1 (en) Gel composition comprising minoxidil
CN113349201A (en) Ethanol-gel-free no-wash disinfectant and preparation method thereof
WO1996032941A1 (en) Pranoprofen eyedrops containing organic amine
TWI711469B (en) Antimicrobial composition and preparation method thereof
CN105961386A (en) Glutaraldehyde foam disinfectant and preparation method thereof
CN110881471A (en) Antimicrobial compositions and methods of making the same
CN111671699A (en) Safe and efficient sterilization type pet shampoo
CN108524923A (en) A kind of gynaecologic antibiotic gel and its production method
JP2006022091A (en) Composition for growing hair
JP2005068076A (en) External liquid preparation containing tranexamic acids and cleaning agent
JP4081521B2 (en) Ciprofloxacin-containing aqueous composition and related uses and processes
JP2008056703A (en) Composition for hair restoration
JP3740090B2 (en) Water-in-oil external preparation
KR20210008251A (en) Ethanol free hand sanitizer with simultaneous moisturizing and disinfecting action and manufacturing method of the same
JP2007191473A (en) New hair-growing composition
JP2005289959A (en) Aqueous solution of olanexidine, method for preparing the same and disinfectant
TWI842183B (en) Oxidative hair dye composition
JP2009235315A (en) Method of manufacturing composition containing powder hardly soluble in water, and method of dissolving powder hardly soluble in water in surfactant solution
CN104434995A (en) Preparation method of mucocutaneous disinfectant